Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）
Clinical trial NCT02072031 · UNKNOWN
Trial details
- NCT number
- NCT02072031
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.